Back to results

Universidad de La Rioja (España)

Structure-guided Cancer Vaccines based on Glycopeptides Supported on Diverse Nanoparticles

Abstract

dc:description

Cancer is a worldwide problem and various cancer therapies are emerging as potential solutions. Among these cancer therapies, a very attractive strategy is that of therapeutic cancer vaccines, which can use tumor-associated peptide fragments that can induce an immune response. In this thesis, we focus on the peptide sequence of MUC1, a glycoprotein presents on the surface of epithelial cells, which leaves simple carbohydrates, and the backbone of the peptide exposed in cancer cells due to aberrant glycosylation. In nature, this exposure to the immune system doesn't trigger a sufficient immune response, due to elusive mechanisms of the cancer cells. For this reason, the core of the present work is to design MUC1-based peptide vaccines modifying the backbone with non-natural mimetics or using different carrier systems to present the antigen to the immune system. In this thesis are presented two vaccines conjugated that have been shown to elicit high immune response utilizing in one case β-amino acid substitutions in the peptide backbone and utilizing as carrier gold nanoparticles, and a second one utilizing an epitope of the MUC1 along with a T helper epitope conjugated to silica nanoparticles. We also present in this work the synthesis of different MUC1 glycopeptides with modifications in the Arg residue and their comparison in terms of affinity towards the SM3 anti-MUC1 monoclonal antibody to select a vaccine candidate among them.

Degree

thesis:*
Grantor dc:publisher
Universidad de La Rioja (España)
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Suárez García, Oscar
Contributors dc:contributor
  • Busto Sancirián, Jesús Héctor (Universidad de La Rioja)
  • García Martín, Fayna M. (Universidad de La Rioja)

Rights

dc:rights
Statement dc:rights
  • LICENCIA DE USO: Los documentos a texto completo incluidos en Dialnet son de acceso libre y propiedad de sus autores y/o editores. Por tanto, cualquier acto de reproducción, distribución, comunicación pública y/o transformación total o parcial requiere el consentimiento expreso y escrito de aquéllos. Cualquier enlace al texto completo de estos documentos deberá hacerse a través de la URL oficial de éstos en Dialnet. Más información: https://dialnet.unirioja.es/info/derechosOAI | INTELLECTUAL PROPERTY RIGHTS STATEMENT: Full text documents hosted by Dialnet are protected by copyright and/or related rights. This digital object is accessible without charge, but its use is subject to the licensing conditions set by its authors or editors. Unless expressly stated otherwise in the licensing conditions, you are free to linking, browsing, printing and making a copy for your own personal purposes. All other acts of reproduction and communication to the public are subject to the licensing conditions expressed by editors and authors and require consent from them. Any link to this document should be made using its official URL in Dialnet. More info: https://dialnet.unirioja.es/info/derechosOAI
Language dc:language
eng

Identifiers

dc:identifier.*
OAI identifier oai:identifier
oai:dialnet.unirioja.es:TES0000023168

Chain of custody

source
Harvested from
Dialnet
Base URL
dialnet.unirioja.es/oaites/OAIHandler
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
related terms
citation

Suárez García, Oscar. Structure-guided Cancer Vaccines based on Glycopeptides Supported on Diverse Nanoparticles. Universidad de La Rioja (España), 2025. https://dialnet.unirioja.es/servlet/oaites?codigo=362824